Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yang has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Bo Wang
Department of Traditional Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250012, China
1 shared publication - Chang Cao
Center for Genomic Medicine Massachusetts General Hospital Boston Massachusetts USA
1 shared publication Chunyan Du
Laboratory Animal Center, School of Medical Sciences, Zhengzhou University, Zhengzhou, Henan, 450052, China
1 shared publication- Jiacheng Guo
Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China
1 shared publication - Jinying Zhang
Department of Cardiology, First Affiliated Hospital of Zhengzhou University, China
1 shared publication - Junnan Tang
Department of Cardiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
1 shared publication
Latest Publications
- Open Access
- 22 August 2021
- Published by KEAI Publishing in Bioactive Materials
- Vol. 10, 56-67
An antioxidant system through conjugating superoxide dismutase onto metal-organic framework for cardiac repair
Acute myocardial infarction (AMI) remains a dominant origin of morbidity, mortality and disability worldwide. Increases in reactive oxygen species (ROS) are key contributor to excessive cardiac injury after AMI. Here we developed an immobilized enzyme with Superoxide Dismutase (SOD) activity cross-link with Zr-based metal-organic framework (ZrMOF) (SOD-ZrMOF) for mitigate ROS-caused injury. In vitro and in vivo evidence indicates that SOD-ZrMOF exhibits excellent biocompatibility. By efficiently scavenging ROS and suppressing oxidative stress, SOD-ZrMOF can protect the function of mitochondria, reduce cell death and alleviate inflammation. More excitingly, long-term study using an animal model of AMI demonstrated that SOD-ZrMOF can reduce the infarct area, protect cardiac function, promote angiogenesis and inhibit pathological myocardial remodeling. Therefore, SOD-ZrMOF holds great potential as an efficacious and safe nanomaterial treatment for AMI.
- 22 August 2021
- Published by KEAI Publishing in Bioactive Materials
- Vol. 10, 56-67
Open AccessAn antioxidant system through conjugating superoxide dismutase onto metal-organic framework for cardiac repair
Acute myocardial infarction (AMI) remains a dominant origin of morbidity, mortality and disability worldwide. Increases in reactive oxygen species (ROS) are key contributor to excessive cardiac injury after AMI. Here we developed an immobilized enzyme with Superoxide Dismutase (SOD) activity cross-link with Zr-based metal-organic framework (ZrMOF) (SOD-ZrMOF) for mitigate ROS-caused injury. In vitro and in vivo evidence indicates that SOD-ZrMOF exhibits excellent biocompatibility. By efficiently scavenging ROS and suppressing oxidative stress, SOD-ZrMOF can protect the function of mitochondria, reduce cell death and alleviate inflammation. More excitingly, long-term study using an animal model of AMI demonstrated that SOD-ZrMOF can reduce the infarct area, protect cardiac function, promote angiogenesis and inhibit pathological myocardial remodeling. Therefore, SOD-ZrMOF holds great potential as an efficacious and safe nanomaterial treatment for AMI.